Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.16(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,419.45
+520.62(+1.04%)

'We sold £1.5m of product in our first week'

Lyma founder on rise of her wellness company

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

4.9100

+0.0400

(+0.82%)

At close: 04:00PM EDT

4.9001

-0.01

(-0.20%)

After hours:

07:43PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	710.07M
Enterprise value	457.19M
Trailing P/E	N/A
Forward P/E	123.46
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	4.01
Price/book (mrq)	1.88
Enterprise value/revenue	2.60
Enterprise value/EBITDA	-7.25

Trading information

Stock price history

Beta (5Y monthly)	1.38
52-week change ³	-56.16%
S&P500 52-week change ³	22.36%
52-week high ³	12.4300
52-week low ³	4.7100
50-day moving average ³	5.2886
200-day moving average ³	7.8797

Share statistics

Avg vol (3-month) ³	2.08M
Avg vol (10-day) ³	1.24M
Shares outstanding ⁵	144.62M
Implied shares outstanding ⁶	144.62M
Float ⁸	131.74M
% held by insiders ¹	7.45%
% held by institutions ¹	38.50%
Shares short (15 Apr 2024) ⁴	11.39M
Short ratio (15 Apr 2024) ⁴	8.02
Short % of float (15 Apr 2024) ⁴	7.90%
Short % of shares outstanding (15 Apr 2024) ⁴	7.88%
Shares short (prior month 15 Mar 2024) ⁴	10.65M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-44.45%
Operating margin (ttm)	-52.72%

Management effectiveness

Return on assets (ttm)	-10.52%
Return on equity (ttm)	-19.92%

Income statement

Revenue (ttm)	175.51M
Revenue per share (ttm)	1.23
Quarterly revenue growth (yoy)	58.60%
Gross profit (ttm)	N/A
EBITDA	-74.14M
Net income avi to common (ttm)	-78.02M
Diluted EPS (ttm)	-0.5400
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	350.37M
Total cash per share (mrq)	2.42
Total debt (mrq)	97.61M
Total debt/equity (mrq)	25.82%
Current ratio (mrq)	5.50
Book value per share (mrq)	2.63

Cash flow statement

Operating cash flow (ttm)	-33.46M
Levered free cash flow (ttm)	-3.89M